Exploring exosomal therapeutics delivery strategies for macular disease
Reducing the risk of end-stage complications of neovascular age-related macular degeneration (AMD): macular atrophy and subretinal fibrosis
Towards a personalised approach to predicting and preventing progression of age-related macular degeneration
Genotype-phenotype correlations in PRPH2-associated retinal dystrophy
Nocturnal hypoxia: An unrecognised risk factor for neovascular age-related macular degeneration
Macular vascular disease: software standardisation and data harmonisation to accelerate the development of new imaging biomarkers and therapies
Next-generation gene therapy for Stargardt Disease: Enhanced AAV-mediated ABCA4 delivery to restore vision
Welcome to the latest edition of Vision Voice.
MDFA is Australia’s largest source of research funding in the field of macular disease outside of government.